Navigation Links
Genoptix, Inc. to Announce Fourth Quarter and Full Year 2007 Financial Results on February 12, 2008
Date:1/30/2008

CARLSBAD, Calif., Jan. 30 /PRNewswire-FirstCall/ -- Genoptix, Inc. (Nasdaq: GXDX), a provider of personalized diagnostic services, announced today that it expects to report its financial results for the fourth quarter and full-year 2007 after closing of the NASDAQ Global Market on Tuesday, February 12, 2008.

A conference call hosted by President and CEO Tina Nova Bennett, Ph.D. and other members of senior management will take place on the same day at 2:00pm PST (5:00pm EST) and will be webcast live on the Genoptix website.

To access the live conference call via phone, dial 888-713-4214 in the U.S. or Canada and 617-213-4866 for other international callers. Please specify to the operator that you would like to join the "Genoptix Fourth Quarter and Full Year 2007 Earnings Call." The participant code for the call is 56532675. If you are unable to listen to the live webcast, a replay of the call will be available through Friday, February 22, 2008. Interested parties can access the rebroadcast by dialing 1-888-286-8010 or 1-617-801-6888 internationally and entering the reservation number 77232785.

The conference call will be webcast live on the Internet and is accessible through the investor relations section of the Genoptix website at http://www.genoptix.com, or by accessing the external website, http://www.fulldisclosure.com. To participate in the webcast, please connect to the Genoptix website several minutes prior to the start time to register, download and install any necessary software that may be required. An online replay is planned to follow shortly after and will be available until Wednesday, March 12, 2008.

About Genoptix, Inc.

Genoptix is a specialized laboratory service provider focused on delivering personalized and comprehensive diagnostic services to community-based hematologists and oncologists. Genoptix is headquartered in Carlsbad, California.

Any statements in this press release or that may be made on the Genoptix conference call about expectations, beliefs, plans, objectives, assumptions or future events or future performance are not historical facts and are forward-looking statements. Forward-looking statements are not guarantees of performance. They involve known and unknown risks, uncertainties and assumptions that may cause actual results, levels of activity, performance or achievements to differ materially from those expressed or implied by any forward-looking statement. For information about risks and uncertainties that Genoptix faces, please refer to the risk factors section of the quarterly report on Form 10-Q for the quarter ended September 30, 2007 filed with the United States Securities and Exchange Commission on December 12, 2007, as well as other subsequent filings with the Securities and Exchange Commission. Genoptix assumes no obligation and expressly disclaims any duty to update any forward-looking statement to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events.


'/>"/>
SOURCE Genoptix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Genoptix, Inc. Announces Pricing for Initial Public Offering
2. Natural Nutrition Announces Forward Split of Common Stock
3. Asthma Foundation Announces 2008 Asthma Capitals, Knoxville on Top Again
4. Healthcare Realty Trust Announces Fourth Quarter Earnings Release Date and Conference Call
5. Wyeth Announces Launch of Own Generic Version of PROTONIX
6. Flextronics Announces Third Quarter Results
7. NightHawk Radiology Holdings, Inc. Announces Date for Fourth Quarter and Full-Year 2007 Earnings Conference Call
8. Healthcare Realty Trust Announces Fourth Quarter Dividend
9. DuPont Announces Leadership Changes
10. BabySupply.Info Announces Launch of Website for New Parents
11. China Medical Technologies to Announce Financial Results for the Third Quarter Ended December 31, 2007 on February 28, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... ... February 27, 2017 , ... Much attention has been paid to the problem ... on opioid painkillers has fallen short. From 1999 until 2010, fatal overdoses from prescription ... fatal overdoses in male populations.(1) , The proportion of women using illicit drugs is ...
(Date:2/27/2017)... ... 27, 2017 , ... Elisa Guajardo Carothers is not your typical author. She went from working ... nun. Now, she writes about God, when she isn’t swimming as a performing mermaid. , ... is BS! (Before Satan),” she offers a comedic look at the dysfunctions of God’s family, ...
(Date:2/27/2017)... Yorba Linda, Ca (PRWEB) , ... February 27, ... ... Coulter Life Sciences, provides an overview on laser diffraction analysis as a tool ... highlighting its capabilities, significance and potential to obtain improved results and novel scientific ...
(Date:2/27/2017)... POUGHKEEPSIE, N. Y. (PRWEB) , ... February 27, 2017 , ... ... Society ( ILADS ) has disclosed that despite scientific studies, the Center for Disease ... of chronic Lyme disease . Kenneth B. Liegner, M.D. has compiled into ...
(Date:2/27/2017)... , ... February 27, 2017 , ... ... and alcohol treatment programs in British Columbia, Canada, at https://www.sunshinecoasthealthcentre.ca/ , is ... team. The new hire, Mackenzie Alsager, showcases the Centre's commitment to innovation in ...
Breaking Medicine News(10 mins):
(Date:2/28/2017)... --  Fourth-quarter 2016 revenues of ... to top end of guidance ... in fourth-quarter 2016 associated with the write-down of goodwill ... reporting unit Fourth-quarter reported ... Full-year 2016 reported $14.48 diluted (GAAP) loss per share ...
(Date:2/27/2017)... 27, 2017 Mederi Therapeutics today announced ... representing 2468 patients who received  Stretta Therapy  to ... " Systematic Review and Meta-Analysis of Controlled and ... Treatment of Gastroesophageal Reflux Disease ", was published in ... Fass , MD, head of the Esophageal and ...
(Date:2/27/2017)... Feb. 27, 2017   Vitasome ® Labs ... supplements using its groundbreaking new liposome technology. Whereas vitamins ... potency through digestion per Physician,s Desk Reference , ... problem of nutritional waste and are scientifically formulated to: ... processes Improve bioavailability with a vastly ...
Breaking Medicine Technology: